RJA
SNV

Raymond James & Associates’s Synovus SNV Stock Holding History

Raymond James & Associates’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.73M Sell
106,355
-8,658
-8% -$379K ﹤0.01% 1688
2024
Q2 		$4.62M Sell
115,013
-8,759
-7% -$332K ﹤0.01% 1634
2024
Q1 		$4.96M Sell
123,772
-3,418
-3% -$128K ﹤0.01% 1588
2023
Q4 		$4.79M Sell
127,190
-27,060
-18% -$827K ﹤0.01% 1565
2023
Q3 		$4.29M Sell
154,250
-24,866
-14% -$778K ﹤0.01% 1558
2023
Q2 		$5.42M Buy
179,116
+23,705
+15% +$693K ﹤0.01% 1422
2023
Q1 		$4.79M Sell
155,411
-11,829
-7% -$450K ﹤0.01% 1488
2022
Q4 		$6.28M Sell
167,240
-8,883
-5% -$353K 0.01% 1264
2022
Q3 		$6.61M Sell
176,123
-1,406
-0.8% -$55.8K 0.01% 1191
2022
Q2 		$6.4M Sell
177,529
-145,799
-45% -$6.03M 0.01% 1240
2022
Q1 		$15.8M Sell
323,328
-11,548
-3% -$585K 0.01% 815
2021
Q4 		$16M Buy
334,876
+184,285
+122% +$8.73M 0.01% 858
2021
Q3 		$6.61M Buy
150,591
+226
+0.2% +$9.55K 0.01% 1315
2021
Q2 		$6.6M Sell
150,365
-4,885
-3% -$229K 0.01% 1314
2021
Q1 		$7.1M Buy
155,250
+7,177
+5% +$301K 0.01% 1218
2020
Q4 		$4.79M Sell
148,073
-109,703
-43% -$3.17M 0.01% 1366
2020
Q3 		$5.46M Buy
257,776
+8,630
+3% +$180K 0.01% 1172
2020
Q2 		$5.12M Buy
249,146
+85,241
+52% +$1.65M 0.01% 1164
2020
Q1 		$2.88M Buy
163,905
+13,021
+9% +$401K ﹤0.01% 1364
2019
Q4 		$5.92M Sell
150,884
-10,318
-6% -$379K 0.01% 1154
2019
Q3 		$5.76M Buy
161,202
+25,521
+19% +$915K 0.01% 1138
2019
Q2 		$4.75M Buy
135,681
+21,702
+19% +$754K 0.01% 1243
2019
Q1 		$3.92M Buy
113,979
+10,507
+10% +$386K 0.01% 1328
2018
Q4 		$3.31M Buy
103,472
+25
+0% +$943 0.01% 1327
2018
Q3 		$4.74M Sell
103,447
-31,837
-24% -$1.6M 0.01% 1238
2018
Q2 		$7.15M Buy
135,284
+5,347
+4% +$284K 0.01% 986
2018
Q1 		$6.49M Buy
129,937
+1,654
+1% +$83.3K 0.01% 999
2017
Q4 		$6.15M Buy
128,283
+9,571
+8% +$453K 0.01% 1019
2017
Q3 		$5.47M Buy
118,712
+28,675
+32% +$1.24M 0.01% 1035
2017
Q2 		$3.98M Buy
90,037
+782
+0.9% +$32.9K 0.01% 1138
2017
Q1 		$3.66M Sell
89,255
-3,359
-4% -$140K 0.01% 1177
2016
Q4 		$3.81M Sell
92,614
-1,358
-1% -$49.9K 0.01% 1135
2016
Q3 		$3.06M Buy
93,972
+12,136
+15% +$381K 0.01% 1212
2016
Q2 		$2.37M Sell
81,836
-7,386
-8% -$224K 0.01% 1236
2016
Q1 		$2.58M Sell
89,222
-25,716
-22% -$737K 0.01% 1138
2015
Q4 		$3.72M Buy
114,938
+852
+0.7% +$27.2K 0.01% 949
2015
Q3 		$3.38M Buy
114,086
+9,049
+9% +$277K 0.01% 943
2015
Q2 		$3.24M Buy
105,037
+3,223
+3% +$93.2K 0.01% 1050
2015
Q1 		$2.85M Buy
101,814
+10,876
+12% +$295K 0.01% 1031
2014
Q4 		$2.46M Buy
90,938
+4,195
+5% +$106K 0.01% 1045
2014
Q3 		$2.05M Sell
86,743
-21,868
-20% -$524K 0.01% 1096
2014
Q2 		$2.65M Sell
108,611
-2,366
-2% -$55.2K 0.02% 946
2014
Q1 		$2.63M Buy
110,977
+4,194
+4% +$102K 0.02% 871
2013
Q4 		$2.69M Buy
106,783
+6,017
+6% +$142K 0.02% 800
2013
Q3 		$2.33M Buy
100,766
+22,115
+28% +$504K 0.02% 799
2013
Q2 		$1.61M Buy
+78,651
New +$1.49M 0.02% 924

Other funds holding SNV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Raymond James & Associates's SNV Position: Q3 2024 in Review

Raymond James & Associates reduced its Synovus (SNV) stake by 7.5% in Q3 2024, selling an estimated $379K and leaving 106,355 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Raymond James & Associates first reported a position in SNV in Q2 2013 and has held it in 46 quarters since. The position peaked at $16M in Q4 2021. 433 funds tracked by Wall St. Rank hold SNV as of Q3 2024.

  • Raymond James & Associates held 106,355 shares of Synovus worth $4.73M as of Q3 2024.
  • Raymond James & Associates sold 8,658 Synovus shares in Q3 2024, an estimated $379K.
  • Synovus made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1688 holding.
  • Raymond James & Associates first reported a position in Synovus in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Synovus position peaked at $16M in Q4 2021.
  • 433 funds tracked by Wall St. Rank held Synovus as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.